C-Reactive Protein Levels Predict Bacterial Exacerbation in Patients With Chronic Obstructive Pulmonary Disease

No abstract is available for this paper.

• Publication year

  2013

• Venue

  American Journal of the Medical Sciences

• Publication date

  2013-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/MAJ.0b013e318253c921PMID 23221507
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers.

  2011cited by this paper
• Acute Exacerbations of COPD: Identification of Biological Clusters and Their Biomarkers

  2011cited by this paper
• Procalcitonin vs C-reactive protein as predictive markers of response to antibiotic therapy in acute exacerbations of COPD.

  2010influential reference
• Relation of sputum colour to bacterial load in acute exacerbations of COPD.

  2009cited by this paper
• Infection in the pathogenesis and course of chronic obstructive pulmonary disease.

  2008cited by this paper
• Inflammatory profile of new bacterial strain exacerbations of chronic obstructive pulmonary disease.

  2008cited by this paper
• Copeptin, C-reactive protein, and procalcitonin as prognostic biomarkers in acute exacerbation of COPD.

  2007cited by this paper
• Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary.

  2007cited by this paper
• Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary.

  2007cited by this paper
• A randomized trial of diagnostic techniques for ventilator-associated pneumonia.

  2006cited by this paper
• Systemic and upper and lower airway inflammation at exacerbation of chronic obstructive pulmonary disease.

  2006cited by this paper
• COPD exacerbations · 2: Aetiology

  2006cited by this paper
• C-reactive protein--can it be used as a marker of infection in patients with exacerbation of chronic obstructive pulmonary disease?

  2006cited by this paper
• CHRONIC OBSTRUCTIVE PULMONARY DISEASE Bronchoscopic validation of the significance of sputum purulence in severe exacerbations of chronic obstructive pulmonary disease

  2006cited by this paper
• Use of plasma biomarkers at exacerbation of chronic obstructive pulmonary disease.

  2006cited by this paper
• Relationships among bacteria, upper airway, lower airway, and systemic inflammation in COPD.

  2005cited by this paper
• Sputum color as a marker of acute bacterial exacerbations of chronic obstructive pulmonary disease.

  2005cited by this paper
• Clinical predictors of bacterial involvement in exacerbations of chronic obstructive pulmonary disease.

  2004cited by this paper
• Burden and clinical features of chronic obstructive pulmonary disease (COPD).

  2004cited by this paper
• Contribution of C-reactive protein to the diagnosis and assessment of severity of community-acquired pneumonia.

  2004cited by this paper
• C-reactive protein levels in community-acquired pneumonia

  2003cited by this paper
• Resolution of bronchial inflammation is related to bacterial eradication following treatment of exacerbations of chronic bronchitis

  2003cited by this paper
• Bacterial infections in patients requiring admission for an acute exacerbation of COPD; a 1-year prospective study.

  2003cited by this paper
• Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations

  2002cited by this paper
• Changes in bronchial inflammation during acute exacerbations of chronic bronchitis.

  2001cited by this paper
• Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease.

  2001cited by this paper
• Bacterial colonization of distal airways in healthy subjects and chronic lung disease: a bronchoscopic study.

  1997cited by this paper
• Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease.

  1987cited by this paper
• Elastolytic activity of sputum and its relation to purulence and to lung function in patients with bronchiectasis.

  1984cited by this paper
• A method of comparing the areas under receiver operating characteristic curves derived from the same cases.

  1983cited by this paper
• The meaning and use of the area under a receiver operating characteristic (ROC) curve.

  1982cited by this paper

• Phenotypes of Exacerbations in Chronic Obstructive Pulmonary Disease

  2025influential citation
• Comparative analysis of lysophospholipid metabolism profiles and clinical characteristics in patients with high vs. low C-reactive protein levels in acute exacerbations of chronic obstructive pulmonary disease.

  2024cites this paper
• Management of Asthma and COPD Exacerbations in Adults in the ICU

  2024cites this paper
• Editorial: Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2023 Guidelines for COPD, Including COVID-19, Climate Change, and Air Pollution

  2023cites this paper
• Phenotypes, Etiotypes, and Endotypes of Exacerbations of Chronic Obstructive Pulmonary Disease.

  2023cites this paper
• Characteristics of the sputum microbiome in COPD exacerbations and correlations between clinical indices

  2022cites this paper
• Analytical performance of 17 commercially available point-of-care tests for CRP to support patient management at lower levels of the health system

  2022cites this paper
• Biomarkers to guide the use of antibiotics for acute exacerbations of COPD (AECOPD): a systematic review and meta-analysis

  2022cites this paper
• Inflammatory Biomarkers Are Inaccurate Indicators of Bacterial Infection on Admission in Patients With Acute Exacerbation of Chronic Obstructive Pulmonary Disease—A Systematic Review and Diagnostic Accuracy Network Meta-Analysis

  2021cites this paper
• Bacterial etiology and pneumococcal urinary antigen in moderate exacerbation of chronic obstructive pulmonary disease

  2021cites this paper
• Antibiotics and COPD: Time to order a C-reactive protein test?

  2021cites this paper
• Can routine hemogram parameters be used as inflammatory biomarker in chronic obstructive pulmonary disease exacerbations?

  2021cites this paper
• MULTI-PHACET: multidimensional clinical phenotyping of hospitalised acute COPD exacerbations

  2021cites this paper
• Blood eosinophils as predictor of outcomes in patients hospitalized for COPD exacerbations: a prospective observational study

  2021cites this paper
• Fractional heat shock protein 27 urine excretion as a short-term predictor in acute exacerbation of chronic obstructive pulmonary disease

  2021influential citation
• Chronic obstructive pulmonary disease (COPD) and lung cancer: common pathways for pathogenesis.

  2019cites this paper
• Inappropriate Utilization of Antibiotics in COPD Exacerbations.

  2019cites this paper
• Low and High Blood Eosinophil Counts as Biomarkers in Hospitalized Acute Exacerbations of COPD.

  2019cites this paper
• Bacterial infections in acute exacerbation of chronic obstructive pulmonary disease: a systematic review and meta-analysis

  2019cites this paper
• Procalcitonin and other markers to guide antibiotic use in chronic obstructive pulmonary disease exacerbations in the era of antimicrobial resistance

  2019cites this paper
• Serum Procalcitonin Level as a Predictor of Bacterial Infection in Patients with COPD Exacerbation

  2019cites this paper
• The association between blood eosinophil percent and bacterial infection in acute exacerbation of chronic obstructive pulmonary disease

  2019cites this paper
• A Revised Treatment Approach for Hospitalized Patients with Eosinophilic and Neutrophilic Exacerbations of Chronic Obstructive Pulmonary Disease.

  2018cites this paper
• Risk Factors for Depression in Patients with Chronic Obstructive Pulmonary Disease

  2018cites this paper
• The YKL-40 protein is a potential biomarker for COPD: a meta-analysis and systematic review

  2018cites this paper
• Clinical and molecular markers in COPD.

  2018cites this paper
• Bronchoalveolar pH and inflammatory biomarkers in patients with acute exacerbation of chronic obstructive pulmonary disease

  2018influential citation
• Managment acute exacerbation of chronic obstructive pulmonary disease

  2018cites this paper
• Outcome of short-term systemic steroid therapy in chronic obstructive pulmonary disease patients with acute exacerbation

  2018cites this paper
• Diagnostic values of C-reactive protein , procalcitonin and serum amyloid A in predicting bacterial infection in patients with acute exacerbations of chronic obstructive pulmonary disease

  2018cites this paper
• [Guideline for the Diagnosis and Treatment of COPD Patients - Issued by the German Respiratory Society and the German Atemwegsliga in Cooperation with the Austrian Society of Pneumology].

  2018cites this paper
• The YKl-40 protein is a potential biomarker for COPD: a meta-analysis and systematic review

  2018cites this paper
• The levels of serum pro-calcitonin and high-sensitivity C-reactive protein in the early diagnosis of chronic obstructive pulmonary disease during acute exacerbation

  2017cites this paper
• The recent advances of phenotypes in acute exacerbations of COPD

  2017cites this paper
• A randomised, placebo-controlled trial of anti–interleukin-1 receptor 1 monoclonal antibody MEDI8968 in chronic obstructive pulmonary disease

  2017cites this paper
• Exploring the interplay between airway bacteria, airway inflammation, lung structure and skeletal muscle dysfunction in COPD

  2017cites this paper
• Tác nhân vi sinh gây viêm phổi cộng đồng phải nhập viện Kết quả nghiên cứu REAL 2016-2017

  2017cites this paper
• Evaluation of new laboratory tests to discriminate bacterial from nonbacterial chronic obstructive pulmonary disease exacerbations

  2016cites this paper
• El marcador sistémico de inflamación PCR fue mejor factor pronóstico de rehospitalización por exacerbación aguda de la enfermedad pulmonar obstructiva crónica que los marcadores de inflamación del esputo

  2016influential citation
• Biological Markers For Chronic Obstructive Pulmonary Disease And Asthma

  2016cites this paper
• Systemic Inflammatory Marker CRP Was Better Predictor of Readmission for AECOPD Than Sputum Inflammatory Markers.

  2016cites this paper
• Airway bacterial colonization and serum C‐reactive protein are associated with chronic obstructive pulmonary disease exacerbation following bronchoscopic lung volume reduction

  2016cites this paper
• Neutrophil CD64 as a Marker of Bacterial Infection in Acute Exacerbations of Chronic Obstructive Pulmonary Disease

  2016cites this paper
• Systemic Inflammatory Marker CRP Was Better Predictor of Readmission for AECOPD Than Sputum Inflammatory Markers

  2016cites this paper
• Predicting In-Hospital Treatment Failure (≤7 days) in Patients with COPD Exacerbation Using Antibiotics and Systemic Steroids

  2016cites this paper
• Defining exacerbations in chronic obstructive pulmonary disease

  2015cites this paper
• Comparison of diagnostic values of procalcitonin, C-reactive protein and blood neutrophil/lymphocyte ratio levels in predicting bacterial infection in hospitalized patients with acute exacerbations of COPD

  2015cites this paper
• Heterogeneity of chronic obstructive pulmonary disease exacerbations: a two-axes classification proposal.

  2015cites this paper
• Serum Amyloid-Beta Levels are Increased in Patients with Chronic Obstructive Pulmonary Disease

  2015cites this paper
• The role of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in exacerbation of chronic obstructive pulmonary disease.

  2015cites this paper
• Prevalence and load of airway bacteria in chronic obstructive pulmonary disease

  2014cites this paper
• Emergency department management of acute exacerbations of chronic obstructive pulmonary disease and factors associated with hospitalization

  2014cites this paper
• High-frequency chest wall oscillation in infective exacerbation of COPD: Is airway secretion clearance the cornerstone?

  2014cites this paper
• Surfactant protein D, Club cell protein 16, Pulmonary and activation-regulated chemokine, C-reactive protein, and Fibrinogen biomarker variation in chronic obstructive lung disease

  2014cites this paper
• Impact of pneumonia on hospitalizations due to acute exacerbations of COPD

  2014cites this paper
• C-Reactive Protein Measurements as a Marker of the Severity of Chronic Obstructive Pulmonary Disease Exacerbations

  2013cites this paper
• Serum C-reactive Protein Level and Distribution in Chronic Obstructive Pulmonary Disease Versus Healthy Controls: a Case–Control Study from Iran

  2013cites this paper
• Personalizing and targeting therapy for COPD – the role of molecular and clinical biomarkers

  2013cites this paper